NCS Multistage Holdings, Inc. Announces Third Quarter 2023 Results
Third Quarter Results
- Total revenues of
$38.3 million , a 22% year-over-year decrease - Net income of
$4.4 million and earnings per diluted share of$1.77 , compared to net income of$3.9 million and earnings per diluted share of$1.58 in the same quarter of 2022 - Adjusted EBITDA of
$6.8 million , a decrease of$1.6 million from the third quarter of 2022; Adjusted EBITDA margin of 18%, an increase compared to the same quarter of 2022 $11.4 million in cash and$8.3 million of total debt as ofSeptember 30, 2023
Financial Review
Total revenues were
Compared to the second quarter of 2023, total revenues increased by 51%, with increases of 97% and 26% in
Gross profit, defined as total revenues less total cost of sales exclusive of depreciation and amortization, for the third quarter of 2023 was
Selling, general and administrative (“SG&A”) expenses totaled
Other income was $2.0 million for the third quarter of 2023 as compared to $0.6 million for the third quarter of 2022. This change was largely due to the recovery of unpaid invoices through settlement of the legal matter in
Net income was
Adjusted EBITDA was
Cash flow from operating activities for the nine months ended
Liquidity and Capital Expenditures
As of
NCS incurred capital expenditures, net of proceeds from the sale of property and equipment, of
Legal Matters
In our previously disclosed legal matter in
During the three months ended
In
Review and Outlook
NCS’s Chief Executive Officer,
While our revenue for the third quarter of 2023 was lower by 22% as compared to the third quarter of 2022, our proactive efforts to improve operational efficiencies and reduce costs contributed to a robust gross margin percentage of 41% and an Adjusted EBITDA margin of 18%, which was slightly higher than our Adjusted EBITDA margin in the third quarter of 2022.
We continue to execute on our strategy to build upon our leading market positions and capitalize on opportunities in international and offshore markets as we bring new and innovative solutions to our customers around the world. We continue to grow our customer base for Repeat Precision products in
The benefits of these efforts are also demonstrated in our year-to-date results, with our Adjusted EBITDA for the first nine months of 2023 of
We have maintained our strong balance sheet, ending the third quarter with a net cash position of
We expect sequential improvements in revenue in our
We have reduced our expectations for customer activity in
I want to express my appreciation to the outstanding people at NCS and at Repeat Precision – it is through the expertise, dedication and ingenuity of this team that we can deliver extraordinary outcomes to our customers, drive innovation in the industry and create value for our shareholders.”
Adjusted EBITDA, Adjusted EBITDA margin, Adjusted EBITDA Less Share-Based Compensation, Adjusted Net Income (Loss), Adjusted Earnings (Loss) per Diluted Share, Free Cash Flow, Free Cash Flow Less Distributions to Non-Controlling Interest and net working capital are non-GAAP financial measures. For an explanation of these measures and a reconciliation, refer to “Non-GAAP Financial Measures” below.
Conference Call
The Company will host a conference call to discuss its third quarter 2023 results and updated guidance on
The replay will be available in the Investors section of the Company’s website shortly after the conclusion of the call and will remain available for approximately seven days.
About
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as “anticipates,” “intends,” “plans,” “seeks,” “believes,” “estimates,” “expects” and similar references to future periods, or by the inclusion of forecasts or projections. Examples of forward-looking statements include, but are not limited to, statements we make regarding the outlook for our future business and financial performance and insurance coverage and appellate prospects for litigation matters. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, by their nature, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. As a result, our actual results may differ materially from those contemplated by the forward-looking statements. Important factors that could cause our actual results to differ materially from those in the forward-looking statements include regional, national or global political, economic, business, competitive, market and regulatory conditions and the following: declines in the level of oil and natural gas exploration and production activity in
Contact
Chief Financial Officer
(281) 453-2222
IR@ncsmultistage.com
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(Unaudited)
Three Months Ended | Nine Months Ended | |||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||
Revenues | ||||||||||||||||
Product sales | $ | 27,286 | $ | 33,965 | $ | 76,149 | $ | 79,549 | ||||||||
Services | 10,993 | 14,905 | 31,075 | 35,897 | ||||||||||||
Total revenues | 38,279 | 48,870 | 107,224 | 115,446 | ||||||||||||
Cost of sales | ||||||||||||||||
Cost of product sales, exclusive of depreciation and amortization expense shown below | 17,118 | 20,754 | 47,945 | 51,910 | ||||||||||||
Cost of services, exclusive of depreciation and amortization expense shown below | 5,449 | 7,640 | 16,564 | 19,210 | ||||||||||||
Total cost of sales, exclusive of depreciation and amortization expense shown below | 22,567 | 28,394 | 64,509 | 71,120 | ||||||||||||
Selling, general and administrative expenses | 12,669 | 15,379 | 43,297 | 45,148 | ||||||||||||
Depreciation | 1,001 | 882 | 2,892 | 2,742 | ||||||||||||
Amortization | 168 | 168 | 502 | 502 | ||||||||||||
Income (loss) from operations | 1,874 | 4,047 | (3,976 | ) | (4,066 | ) | ||||||||||
Other income (expense) | ||||||||||||||||
Interest expense, net | (27 | ) | (204 | ) | (447 | ) | (794 | ) | ||||||||
Provision for litigation, net of recoveries | (98 | ) | — | (42,498 | ) | — | ||||||||||
Other income, net | 1,983 | 564 | 3,753 | 1,556 | ||||||||||||
Foreign currency exchange loss, net | (157 | ) | (563 | ) | (79 | ) | (562 | ) | ||||||||
Total other income (expense) | 1,701 | (203 | ) | (39,271 | ) | 200 | ||||||||||
Income (loss) before income tax | 3,575 | 3,844 | (43,247 | ) | (3,866 | ) | ||||||||||
Income tax benefit | (537 | ) | (120 | ) | (287 | ) | (623 | ) | ||||||||
Net income (loss) | 4,112 | 3,964 | (42,960 | ) | (3,243 | ) | ||||||||||
Net (loss) income attributable to non-controlling interest | (296 | ) | 29 | (168 | ) | (162 | ) | |||||||||
Net income (loss) attributable to NCS Multistage Holdings, Inc. | $ | 4,408 | $ | 3,935 | $ | (42,792 | ) | $ | (3,081 | ) | ||||||
Earnings (loss) per common share | ||||||||||||||||
Basic earnings (loss) per common share attributable to NCS Multistage Holdings, Inc. | $ | 1.78 | $ | 1.61 | $ | (17.33 | ) | $ | (1.27 | ) | ||||||
Diluted earnings (loss) per common share attributable to NCS Multistage Holdings, Inc. | $ | 1.77 | $ | 1.58 | $ | (17.33 | ) | $ | (1.27 | ) | ||||||
Weighted average common shares outstanding | ||||||||||||||||
Basic | 2,479 | 2,438 | 2,469 | 2,430 | ||||||||||||
Diluted | 2,489 | 2,488 | 2,469 | 2,430 |
CONDENSED CONSOLIDATED BALANCE SHEETS*
(In thousands, except share data)
(Unaudited)
2023 | 2022 | |||||||
Assets | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ | 11,398 | $ | 16,234 | ||||
Accounts receivable—trade, net | 30,252 | 27,846 | ||||||
Inventories, net | 42,035 | 37,042 | ||||||
Prepaid expenses and other current assets | 2,342 | 2,815 | ||||||
Other current receivables | 4,037 | 3,726 | ||||||
Total current assets | 90,064 | 87,663 | ||||||
Noncurrent assets | ||||||||
Property and equipment, net | 24,390 | 23,316 | ||||||
15,222 | 15,222 | |||||||
Identifiable intangibles, net | 4,574 | 5,076 | ||||||
Operating lease assets | 5,138 | 4,515 | ||||||
Deposits and other assets | 2,057 | 2,761 | ||||||
Deferred income taxes, net | 257 | 46 | ||||||
Total noncurrent assets | 51,638 | 50,936 | ||||||
Total assets | $ | 141,702 | $ | 138,599 | ||||
Liabilities and Stockholders’ Equity | ||||||||
Current liabilities | ||||||||
Accounts payable—trade | $ | 9,402 | $ | 7,549 | ||||
Accrued expenses | 5,065 | 4,391 | ||||||
Income taxes payable | 16 | 468 | ||||||
Operating lease liabilities | 1,562 | 1,274 | ||||||
Current maturities of long-term debt | 1,755 | 1,489 | ||||||
Other current liabilities | 2,031 | 2,522 | ||||||
Total current liabilities | 19,831 | 17,693 | ||||||
Noncurrent liabilities | ||||||||
Long-term debt, less current maturities | 6,543 | 6,437 | ||||||
Operating lease liabilities, long-term | 4,125 | 3,680 | ||||||
Accrual for legal contingencies | 40,750 | — | ||||||
Other long-term liabilities | 1,281 | 1,328 | ||||||
Deferred income taxes, net | 486 | 199 | ||||||
Total noncurrent liabilities | 53,185 | 11,644 | ||||||
Total liabilities | 73,016 | 29,337 | ||||||
Commitments and contingencies | ||||||||
Stockholders’ equity | ||||||||
Preferred stock, |
— | — | ||||||
Common stock, |
25 | 24 | ||||||
Additional paid-in capital | 443,759 | 440,475 | ||||||
Accumulated other comprehensive loss | (86,253 | ) | (85,617 | ) | ||||
Retained deficit | (305,256 | ) | (262,464 | ) | ||||
(1,654 | ) | (1,389 | ) | |||||
Total stockholders' equity | 50,621 | 91,029 | ||||||
Non-controlling interest | 18,065 | 18,233 | ||||||
Total equity | 68,686 | 109,262 | ||||||
Total liabilities and stockholders' equity | $ | 141,702 | $ | 138,599 |
_____________________
- Preliminary
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
Nine Months Ended | ||||||||
2023 | 2022 | |||||||
Cash flows from operating activities | ||||||||
Net loss | $ | (42,960 | ) | $ | (3,243 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Depreciation and amortization | 3,394 | 3,244 | ||||||
Amortization of deferred loan costs | 153 | 180 | ||||||
Write-off of deferred loan costs | — | 196 | ||||||
Share-based compensation | 4,198 | 4,490 | ||||||
Provision for inventory obsolescence | 256 | 1,885 | ||||||
Deferred income tax expense | 147 | 109 | ||||||
Gain on sale of property and equipment | (423 | ) | (339 | ) | ||||
Provision for (recovery of) credit losses | 112 | (60 | ) | |||||
Provision for litigation, net of recoveries | 42,498 | — | ||||||
Proceeds from note receivable | 338 | 474 | ||||||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable—trade | (2,593 | ) | (12,534 | ) | ||||
Inventories, net | (6,356 | ) | (4,013 | ) | ||||
Prepaid expenses and other assets | 544 | 1,868 | ||||||
Accounts payable—trade | 2,824 | 2,274 | ||||||
Accrued expenses | (1,025 | ) | (161 | ) | ||||
Other liabilities | (2,334 | ) | (2,509 | ) | ||||
Income taxes receivable/payable | (219 | ) | (897 | ) | ||||
Net cash used in operating activities | (1,446 | ) | (9,036 | ) | ||||
Cash flows from investing activities | ||||||||
Purchases of property and equipment | (1,704 | ) | (768 | ) | ||||
Purchase and development of software and technology | (263 | ) | (78 | ) | ||||
Proceeds from sales of property and equipment | 454 | 406 | ||||||
Net cash used in investing activities | (1,513 | ) | (440 | ) | ||||
Cash flows from financing activities | ||||||||
Payments on finance leases | (1,159 | ) | (1,090 | ) | ||||
Line of credit borrowings | 11,702 | 10,214 | ||||||
Payments of line of credit borrowings | (11,758 | ) | (10,189 | ) | ||||
(265 | ) | (382 | ) | |||||
Payment of deferred loan cost related to ABL facility | — | (940 | ) | |||||
Net cash used in financing activities | (1,480 | ) | (2,387 | ) | ||||
Effect of exchange rate changes on cash and cash equivalents | (397 | ) | (428 | ) | ||||
Net change in cash and cash equivalents | (4,836 | ) | (12,291 | ) | ||||
Cash and cash equivalents beginning of period | 16,234 | 22,168 | ||||||
Cash and cash equivalents end of period | $ | 11,398 | $ | 9,877 | ||||
Noncash investing and financing activities | ||||||||
Assets obtained in exchange for new finance lease liabilities | $ | 1,665 | $ | 1,477 | ||||
Assets obtained in exchange for new operating lease liabilities | $ | 1,791 | $ | 1,205 |
REVENUES BY GEOGRAPHIC AREA
(In thousands)
(Unaudited)
Three Months Ended | Nine Months Ended | ||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||
Product sales | $ | 5,200 | $ | 8,217 | $ | 20,202 | $ | 24,551 | |||
Services | 2,812 | 3,294 | 8,511 | 8,171 | |||||||
Total |
8,012 | 11,511 | 28,713 | 32,722 | |||||||
Product sales | 21,531 | 25,748 | 54,062 | 54,455 | |||||||
Services | 6,613 | 9,011 | 19,074 | 21,681 | |||||||
Total |
28,144 | 34,759 | 73,136 | 76,136 | |||||||
Other Countries | |||||||||||
Product sales | 555 | — | 1,885 | 543 | |||||||
Services | 1,568 | 2,600 | 3,490 | 6,045 | |||||||
Total Other Countries | 2,123 | 2,600 | 5,375 | 6,588 | |||||||
Total | |||||||||||
Product sales | 27,286 | 33,965 | 76,149 | 79,549 | |||||||
Services | 10,993 | 14,905 | 31,075 | 35,897 | |||||||
Total revenues | $ | 38,279 | $ | 48,870 | $ | 107,224 | $ | 115,446 |
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION
(In thousands, except per share data)
(Unaudited)
Non-GAAP Financial Measures
EBITDA is defined as net income (loss) before interest expense, net, income tax expense and depreciation and amortization. Adjusted EBITDA is defined as EBITDA adjusted to exclude certain items which we believe are not reflective of ongoing operating performance or which, in the case of share-based compensation, is non-cash in nature. Adjusted EBITDA margin represents Adjusted EBITDA as a percentage of total revenues. Adjusted EBITDA Less Share-Based Compensation is defined as Adjusted EBITDA minus share-based compensation expense. Adjusted Net Income (Loss) is defined as net income (loss) attributable to
EBITDA, Adjusted EBITDA, Adjusted EBITDA margin, Adjusted EBITDA Less Share-Based Compensation, Adjusted Net Income (Loss), Adjusted Earnings (Loss) per Diluted Share, Free Cash Flow, Free Cash Flow Less Distributions to Non-Controlling Interest and net working capital (our “non-GAAP financial measures”) are not defined under generally accepted accounting principles (“GAAP”), are not measures of net income (loss), income (loss) from operations, cash (used in) provided by operating activities, working capital or any other performance measure derived in accordance with GAAP, and are subject to important limitations. Our non-GAAP financial measures may not be comparable to similarly titled measures of other companies in our industry and are not measures of performance calculated in accordance with GAAP. Our non-GAAP financial measures have important limitations as analytical tools and you should not consider them in isolation or as substitutes for analysis of our financial performance as reported under GAAP, and they should not be considered as alternatives to net income (loss), income (loss) from operations, cash (used in) provided by operating activities, working capital or any other performance measures derived in accordance with GAAP as measures of operating performance or as alternatives to cash flow from operating activities as measures of our liquidity.
The tables below set forth reconciliations of our non-GAAP financial measures to the most directly comparable measures of financial performance calculated under GAAP:
NET WORKING CAPITAL*
2023 | 2022 | |||||||
Working capital | $ | 70,233 | $ | 69,970 | ||||
Cash and cash equivalents | (11,398 | ) | (16,234 | ) | ||||
Current maturities of long term debt | 1,755 | 1,489 | ||||||
Net working capital | $ | 60,590 | $ | 55,225 |
_____________________
- Preliminary
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION
(In thousands, except per share data)
(Unaudited)
ADJUSTED NET INCOME (LOSS) AND ADJUSTED EARNINGS (LOSS) PER DILUTED SHARE
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||
Effect on Net Income |
Impact on Diluted Earnings Per Share |
Effect on Net Income |
Impact on Diluted Earnings Per Share |
Effect on Net (Loss) Income |
Impact on Diluted (Loss) Earnings Per Share (e) |
Effect on Net Loss |
Impact on Diluted Loss Per Share |
||||||||||||||||||||
Net income (loss) attributable to NCS Multistage Holdings, Inc. | $ | 4,408 | $ | 1.77 | $ | 3,935 | $ | 1.58 | $ | (42,792 | ) | $ | (17.33 | ) | $ | (3,081 | ) | $ | (1.27 | ) | |||||||
Adjustments | |||||||||||||||||||||||||||
Provision for litigation, net of recoveries (a) | 98 | 0.04 | — | — | 42,498 | 17.21 | — | — | |||||||||||||||||||
Foreign currency exchange loss (b) | 237 | 0.10 | 580 | 0.24 | 132 | 0.06 | 562 | 0.23 | |||||||||||||||||||
Write-off of deferred loan costs (c) | — | — | — | — | — | — | 196 | 0.08 | |||||||||||||||||||
Income tax impact from adjustments (d) | 1 | — | 12 | — | 303 | 0.12 | (138 | ) | (0.05 | ) | |||||||||||||||||
Adjusted net income (loss) attributable to |
$ | 4,744 | $ | 1.91 | $ | 4,527 | $ | 1.82 | $ | 141 | $ | 0.06 | $ | (2,461 | ) | $ | (1.01 | ) |
__________________
(a) Represents litigation provision associated with certain litigation matters, which is primarily related to a judgment in
(b) Represents realized and unrealized foreign currency exchange gains and losses attributable to
(c) Represents deferred loan costs of
(d) Represents income tax impacts based on applicable effective tax rates. The 2022 amounts were changed from prior presentation to exclude the effect of valuation allowance adjustments.
(e) Earnings per share calculated using the basic weighted average share; net loss per GAAP has been adjusted to arrive at Adjusted Net Income for the nine months ended
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION
(In thousands)
(Unaudited)
ADJUSTED EBITDA, ADJUSTED EBITDA MARGIN, AND ADJUSTED EBITDA LESS SHARE-BASED COMPENSATION
Three Months Ended | Nine Months Ended | |||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||
Net income (loss) | $ | 4,112 | $ | 3,964 | $ | (42,960 | ) | $ | (3,243 | ) | ||||||
Income tax benefit | (537 | ) | (120 | ) | (287 | ) | (623 | ) | ||||||||
Interest expense, net | 27 | 204 | 447 | 794 | ||||||||||||
Depreciation | 1,001 | 882 | 2,892 | 2,742 | ||||||||||||
Amortization | 168 | 168 | 502 | 502 | ||||||||||||
EBITDA | 4,771 | 5,098 | (39,406 | ) | 172 | |||||||||||
Provision for litigation, net of recoveries (a) | 98 | — | 42,498 | — | ||||||||||||
Share-based compensation (b) | 1,328 | 854 | 3,285 | 2,500 | ||||||||||||
Professional fees (c) | (375 | ) | 1,674 | 1,286 | 4,819 | |||||||||||
Foreign currency exchange loss (d) | 157 | 563 | 79 | 562 | ||||||||||||
Severance and other termination benefits (e) | 671 | — | 980 | — | ||||||||||||
Other (f) | 145 | 237 | 698 | 659 | ||||||||||||
Adjusted EBITDA | $ | 6,795 | $ | 8,426 | $ | 9,420 | $ | 8,712 | ||||||||
Adjusted EBITDA Margin | 18 | % | 17 | % | 9 | % | 8 | % | ||||||||
Adjusted EBITDA Less Share-Based Compensation | $ | 5,467 | $ | 7,572 | $ | 6,135 | $ | 6,212 |
___________________
(a) Represents litigation provision associated with certain litigation matters, which is primarily related to a judgment in
(b) Represents non-cash compensation charges related to share-based compensation granted to our officers, employees and directors.
(c) Represents non-capitalizable costs of professional services primarily incurred or reversed in connection with our legal proceedings.
(d) Represents realized and unrealized foreign currency exchange gains and losses primarily due to movement in the foreign currency exchange rates during the applicable periods.
(e) Represents certain expenses associated with consolidations of our tracer diagnostics business operations and Repeat Precision’s manufacturing operations in
(f) Represents the impact of a research and development subsidy that is included in income tax expense in accordance with GAAP along with other charges and credits.
FREE CASH FLOW AND FREE CASH FLOW LESS DISTRIBUTIONS TO NON-CONTROLLING INTEREST
Nine Months Ended | ||||||||
2023 | 2022 | |||||||
Net cash used in operating activities | $ | (1,446 | ) | $ | (9,036 | ) | ||
Purchases of property and equipment | (1,704 | ) | (768 | ) | ||||
Purchase and development of software and technology | (263 | ) | (78 | ) | ||||
Proceeds from sales of property and equipment | 454 | 406 | ||||||
Free cash flow | $ | (2,959 | ) | $ | (9,476 | ) | ||
Distributions to non-controlling interest | — | — | ||||||
Free cash flow less distributions to non-controlling interest | $ | (2,959 | ) | $ | (9,476 | ) |
Source: NCS Multistage Holdings, Inc.